GNH USA

Europe — EMA

Normalip (Atorvastatin)

GNH USA supplies Normalip (Atorvastatin), a HMG‑CoA reductase inhibitor for hypercholesterolemia and cardiovascular risk reduction.

Atorvastatin

Request sourcing

1
Pack/s

What is Atorvastatin?

Atorvastatin, the active ingredient in Normalip, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It belongs to the statin class of lipid‑lowering agents and is indicated for patients requiring reduction of low‑density lipoprotein cholesterol. It treats hypercholesterolemia and helps prevent cardiovascular events in patients with established risk factors.

GNH USA supplies Normalip as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to healthcare institutions.

What is Atorvastatin used for?

Atorvastatin is used to manage disorders of lipid metabolism and to reduce cardiovascular risk.

- Hypercholesterolemia: lowers LDL‑cholesterol and total cholesterol levels. - Primary hyperlipidemia: reduces triglycerides and raises HDL‑cholesterol. - Prevention of cardiovascular events: decreases the incidence of myocardial infarction, stroke and related complications in patients with risk factors.

What are the side effects of Atorvastatin?

Common side effects are generally mild and transient.

Common Side Effects: - Muscle pain (myalgia) - Elevated liver enzymes (ALT/AST) - Headache - Gastrointestinal discomfort (nausea, abdominal pain)

Serious or Rare Side Effects: - Rhabdomyolysis - Severe liver injury - Allergic reactions (including anaphylaxis)

What precautions apply to Atorvastatin?

Before initiating therapy, consider the following precautions.

- Liver function monitoring: assess baseline and periodic liver enzymes. - Muscle symptoms monitoring: discontinue if unexplained muscle pain with CK elevation. - Drug interactions: review concomitant medications that affect statin metabolism. - Pregnancy and lactation: avoid use; safety not established. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Atorvastatin interact with?

Atorvastatin may interact with several medicines; categorize them as follows.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may increase atorvastatin levels. - Gemfibrozil: increased risk of myopathy. - Cyclosporine: elevated statin exposure.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance anticoagulant effect. - Antidiabetic drugs (insulin, sulfonylureas): may affect glucose control.

Frequently asked questions

What is Normalip used for?+
Normalip contains atorvastatin, a statin indicated for the treatment of hypercholesterolemia and other primary lipid disorders. It helps lower low‑density lipoprotein (LDL) cholesterol, reduce total cholesterol, and modestly raise high‑density lipoprotein (HDL) cholesterol. In addition, it is prescribed to lower the risk of cardiovascular events such as heart attack and stroke in patients with established risk factors.
How does atorvastatin work?+
Atorvastatin works by competitively inhibiting the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. This inhibition reduces the production of cholesterol within hepatocytes, leading to an up‑regulation of LDL receptors on the cell surface. The increased receptor density enhances the removal of LDL particles from the bloodstream, thereby lowering plasma cholesterol levels.
What is the usual dose of Normalip?+
The dosage of Normalip is individualized by the prescribing healthcare professional based on the patient’s lipid profile, cardiovascular risk, age, renal and hepatic function, and concomitant medications. The prescriber determines the appropriate strength and titration schedule, and patients should follow the exact instructions provided on the prescription label.
Is Normalip safe during pregnancy or breastfeeding?+
Safety of atorvastatin in pregnancy and lactation has not been established. Statins are generally contraindicated during pregnancy because cholesterol synthesis is essential for fetal development. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid Normalip unless the potential benefit outweighs the risk and it is specifically advised by a qualified clinician.
How do I order Normalip from GNH USA?+
To place an order, submit an enquiry on the Normalip product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any special handling—and assists with the necessary import documentation.
How does Normalip compare with other statins?+
Normalip (atorvastatin) is a high‑potency statin with a long half‑life, allowing flexible dosing and strong LDL‑cholesterol reduction compared with lower‑intensity agents such as pravastatin or lovastatin. It shares the same class‑related safety profile but may have a higher risk of drug‑interaction when combined with strong CYP3A4 inhibitors. Choice of statin depends on efficacy goals, patient tolerance, and potential interactions.
How should Normalip be stored?+
Normalip should be stored at ambient temperature below 25 °C (77 °F). Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed. Do not store in the bathroom or near heat sources, and keep out of reach of children.
How is Normalip administered?+
Normalip is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a full glass of water and not chewed, crushed, or split unless the prescriber specifically advises otherwise. Consistency in the time of day helps maintain steady drug levels, and patients should follow the dosing schedule prescribed by their clinician.
What are the most serious risks associated with Normalip?+
The most serious adverse reactions to monitor are rhabdomyolysis, a severe form of muscle breakdown that can lead to kidney failure, and significant liver injury indicated by marked elevations in transaminases. Patients should report unexplained muscle pain, weakness, dark urine, or persistent fatigue promptly. Prompt discontinuation and medical evaluation are essential if these symptoms occur.
Who should not use Normalip?+
Normalip is contraindicated in individuals with active liver disease, unexplained persistent elevations of serum transaminases, or known hypersensitivity to atorvastatin or any component of the formulation. It should also be avoided in patients taking contraindicated medications such as strong CYP3A4 inhibitors (e.g., certain antifungals, macrolide antibiotics) or gemfibrozil, unless the prescriber determines that the benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Atorvastatin
Route
Oral Use
Manufacturer
Towa Pharmaceutical S.A.
Origin
EU

Related products

Abator

Abator

Atorvastatin

Sapiens Pharmaceuticals Ltd
EU
Altoram

Altoram

Atorvastatin

Libytec Pharmaceutical S.A.
EU
Amedo

Amedo

Atorvastatin

Medochemie Bohemia, Spol. S R.O.
EU
Amicor

Amicor

Atorvastatin

Medochemie Ltd.
EU